Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of 6% Miltefosine Solution, a Topical Chemotherapy in Cutaneous Metastases From Breast Cancer
- 1 November 2001
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (21) , 4150-4159
- https://doi.org/10.1200/jco.2001.19.21.4150
Abstract
PURPOSE: To compare 6% miltefosine solution (Miltex; Asta Medica, Frankfurt, Germany), a new topical cytostatic drug, with placebo as palliative treatment for cutaneous metastases from breast cance...Keywords
This publication has 16 references indexed in Scilit:
- Local recurrence after breast conservation therapy for early stage breast carcinomaCancer, 1999
- Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM)European Journal Of Cancer, 1999
- Inhibitors of signal transduction: The alkylphosphocholinesDrug News & Perspectives, 1999
- Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast CancerNew England Journal of Medicine, 1997
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyNew England Journal of Medicine, 1997
- Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosisCancer, 1989
- The Implications of Local Recurrence of Breast Cancer as the First Site of Therapeutic FailureAnnals of Surgery, 1983
- Prognostic indicators in patients with isolated local–regional recurrence of breast cancerCancer, 1981
- The significance of recurrence in breast cancerBritish Journal of Surgery, 1966
- Frequency, anatomical distribution and management of local recurrences after definitive therapy for breast cancerCancer, 1966